Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...

Live bacteria can be applied in cancer therapy given their ability to deplete nutrients and induce cell death in tumors. However, the interaction between bacteria and tumor cells is risky and can ...